# Tumor TARGET Prostate Cancer

> **NCT01802242** · NA · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 85 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Volumetric Modulated Arc Therapy (VMAT) and High-Dose Rate (HDR) Radiotherapy
- **OTHER:** No Active Treatment - completed Prior Radiation

## Key facts

- **NCT ID:** NCT01802242
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-10
- **Primary completion:** 2025-05
- **Final completion:** 2025-05
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2024-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01802242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01802242, "Tumor TARGET Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01802242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*